​

Glaukos (GKOS) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

GKOS Stock Forecast

Glaukos (GKOS) stock forecast, based on 24 Wall Street analysts, predicts a 12-month average price target of $117.40, with a high of $135.00 and a low of $103.00. This represents a 50.92% increase from the last price of $77.79.

$75 $90 $105 $120 $135 $150 High: $135 Avg: $117.4 Low: $103 Last Closed Price: $77.79

GKOS Stock Rating

Glaukos stock's rating consensus is Buy, based on 24 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 18 Buy (75.00%), 5 Hold (20.83%), 1 Sell (4.17%), and 0 Strong Sell (0.00%).

Buy
Total 24 0 1 5 18 Strong Sell Sell Hold Buy Strong Buy

GKOS Price Target Upside V Benchmarks

TypeNameUpside
StockGlaukos50.92%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks20.18%

Price Target Trends

1M3M12M
# Anlaysts3411
Avg Price Target$107.33$113.00$137.18
Last Closing Price$77.79$77.79$77.79
Upside/Downside37.97%45.26%76.35%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 2531021-16
Sep, 253921-15
Aug, 253921-15
Jul, 253921-15
Jun, 253921-15
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 27, 2025Thomas StephanStifel Nicolaus$115.00$74.6754.01%47.83%
Oct 13, 2025Ryan ZimmermanBTIG$104.00$82.5625.97%33.69%
Oct 01, 2025Goldman Sachs$103.00$81.5526.30%32.41%
Jul 31, 2025Mizuho Securities$130.00$94.0538.22%67.12%
May 01, 2025Richard NewitterTruist Financial$135.00$83.5461.60%73.54%
Dec 31, 2024Thomas StephanStifel Nicolaus$175.00$149.9416.71%124.96%
Dec 18, 2024Richard NewitterTruist Financial$185.00$145.1427.46%137.82%
Dec 02, 2024Thomas StephanStifel Nicolaus$153.00$140.189.15%96.68%
Dec 02, 2024Patrick WoodMorgan Stanley$120.00$140.80-14.77%54.26%
Nov 05, 2024David SaxonNeedham$149.00$127.4516.91%91.54%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 27, 2025Wells FargoBuyOverweightupgrade
Oct 13, 2025BTIGBuyBuyhold
Oct 01, 2025Goldman SachsBuyinitialise
Jul 14, 2025BTIGBuyBuyhold
Jan 03, 2025BTIGBuyBuyhold
Dec 11, 2024CitigroupBuyBuyupgrade
Dec 02, 2024Morgan StanleyEqual-WeightUnderweightdowngrade
Oct 29, 2024JefferiesBuyBuyhold
Oct 17, 2024Piper SandlerOverweightOverweighthold
Sep 23, 2024BTIGBuyBuyhold

Financial Forecast

EPS Forecast

$-3 $-2 $-1 $0 $1 $2 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.70$-1.07$-2.09$-2.78$-2.77----
Avg Forecast$-1.50$-0.88$-2.20$-2.22$-1.82$-1.05$-0.25$0.42$1.18
High Forecast$-1.40$-0.82$-2.02$-2.16$-1.71$-0.75$0.08$0.44$1.24
Low Forecast$-1.58$-0.92$-2.30$-2.26$-2.00$-1.32$-0.38$0.39$1.12
Surprise %80.00%21.59%-5.00%25.23%52.20%----

Revenue Forecast

$200M $360M $520M $680M $840M $1B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$224.96M$294.01M$282.86M$314.71M$383.48M----
Avg Forecast$220.00M$288.16M$279.63M$313.00M$378.54M$479.13M$609.94M$745.10M$916.05M
High Forecast$228.57M$299.38M$289.59M$313.16M$378.96M$499.83M$610.76M$776.53M$954.70M
Low Forecast$208.57M$273.19M$261.89M$312.87M$377.81M$458.02M$609.12M$713.86M$877.64M
Surprise %2.25%2.03%1.16%0.55%1.31%----

Net Income Forecast

$-200M $-140M $-80M $-20M $40M $100M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-120.35M$-49.59M$-99.19M$-134.66M$-146.37M----
Avg Forecast$-139.09M$-60.89M$-56.35M$-134.66M$-89.64M$-50.13M$-7.30M$20.10M$57.15M
High Forecast$-111.27M$-45.79M$-39.19M$-95.11M$-82.63M$-36.24M$4.00M$21.20M$60.29M
Low Forecast$-166.91M$-75.99M$-73.50M$-174.21M$-96.64M$-64.01M$-18.60M$19.00M$54.04M
Surprise %-13.47%-18.55%76.04%-63.29%----

GKOS Forecast FAQ

Is Glaukos stock a buy?

Glaukos stock has a consensus rating of Buy, based on 24 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 18 Buy, 5 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Glaukos is a favorable investment for most analysts.

What is Glaukos's price target?

Glaukos's price target, set by 24 Wall Street analysts, averages $117.4 over the next 12 months. The price target range spans from $103 at the low end to $135 at the high end, suggesting a potential 50.92% change from the previous closing price of $77.79.

How does Glaukos stock forecast compare to its benchmarks?

Glaukos's stock forecast shows a 50.92% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical device stocks industry (20.18%).

What is the breakdown of analyst ratings for Glaukos over the past three months?

  • October 2025: 18.75% Strong Buy, 62.50% Buy, 12.50% Hold, 6.25% Sell, 0% Strong Sell.
  • September 2025: 20.00% Strong Buy, 60.00% Buy, 13.33% Hold, 6.67% Sell, 0% Strong Sell.
  • August 2025: 20.00% Strong Buy, 60.00% Buy, 13.33% Hold, 6.67% Sell, 0% Strong Sell.

What is Glaukos’s EPS forecast?

Glaukos's average annual EPS forecast for its fiscal year ending in December 2025 is $-1.05, marking a -62.09% decrease from the reported $-2.77 in 2024. Estimates for the following years are $-0.25 in 2026, $0.42 in 2027, and $1.18 in 2028.

What is Glaukos’s revenue forecast?

Glaukos's average annual revenue forecast for its fiscal year ending in December 2025 is $479.13M, reflecting a 24.94% increase from the reported $383.48M in 2024. The forecast for 2026 is $609.94M, followed by $745.1M for 2027, and $916.05M for 2028.

What is Glaukos’s net income forecast?

Glaukos's net income forecast for the fiscal year ending in December 2025 stands at $-50.125M, representing a -65.75% decrease from the reported $-146M in 2024. Projections indicate $-7.3M in 2026, $20.1M in 2027, and $57.15M in 2028.